European Reimbursement/Germany

Germany · DiGA · Provisional

memodio

memodio GmbH

About this entry

memodio is a digital health app from memodio GmbH with a provisional DiGA listing in Germany's DiGA directory (BfArM id 02866). It is indicated for Leichte kognitive Störung. First listed on 2025-12-27. The provisional trial period ends 2026-12-26. The public prescription price is EUR 595 for a 90-day unit. German statutory health insurers reimburse prescribed use under the Digital Healthcare Act rules. This page is not legal or reimbursement advice; confirm the current entry on the official BfArM listing.

App
memodio
Maker
memodio GmbH
Country
Germany
Program
DiGA
Status
Provisional
Indication detail
F06.7 Leichte kognitive Störung; F00 Demenz bei Alzheimer-Krankheit; F01 Vaskuläre Demenz; R42 Schwindel und Taumel
Indication codes
F06.7, F00, F01, R42
Listing date
2025-12-27
Provisional listing ends
2026-12-26
Public price
EUR 595.00 per 90-day unit
BfArM DiGA id
02866

Not legal or reimbursement advice. Confirm the current entry with the official source.